EP Patent

EP2327381A1 — Sterilisation device

Assigned to Individual · Expires 2011-06-01 · 15y expired

What this patent protects

Apparatus (1 M) for sterilisation of a female mammal comprising at least one separation member (307) for separation of a fallopian tube (15) from a uterine cavity (17) of the female mammal, a circulation assembly which is operatively connected to said at least one separation memb…

USPTO Abstract

Apparatus (1 M) for sterilisation of a female mammal comprising at least one separation member (307) for separation of a fallopian tube (15) from a uterine cavity (17) of the female mammal, a circulation assembly which is operatively connected to said at least one separation member (307), and at least one sterilisation lumen (4b) which is operatively connected to said circulation assembly and debouching at a distal side of said at least one separation member (307), said at least one sterilisation lumen (4b) being adapted for injection in use of a tissue necrotising fluid capable of necrotising a lining of at least a part of said fallopian tube (15), wherein said circulation assembly is adapted to circulate said tissue necrotising fluid within said sterilisation lumen (4b) and said fallopian tube (15). The apparatus (1 M) allows quick, simple, safe and reliable sterilisation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2327381A1
Jurisdiction
EP
Classification
Expires
2011-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.